Koshoedo Sejlo, Soiza Roy L, Purkayastha Rajib, Mangoni Arduino A
Department of Rehabilitation Medicine, Woodend Hospital, NHS Grampian, Aberdeen, United Kingdom.
Am J Geriatr Pharmacother. 2012 Aug;10(4):251-7. doi: 10.1016/j.amjopharm.2012.06.003. Epub 2012 Jul 13.
Medications with anticholinergic (antimuscarinic) effects negatively affect physical and cognitive function in community-dwelling older patients. However, it is unknown if anticholinergic drugs exert detrimental effects in older patients undergoing rehabilitation.
The purpose of our study was to assess the effect of anticholinergic drug exposure on functional outcomes in older patients undergoing rehabilitation. We speculated that higher anticholinergic drug exposure would be associated with reduced functional outcomes in this group.
Data on clinical characteristics, full medication, anticholinergic drug exposure (total number of anticholinergic drugs [tAD] and Anticholinergic Risk Scale [ARS] score), and Barthel index (BI) score were collected on admission and discharge in a consecutive series of 117 older patients (age 79 [7] years) admitted to the orthopaedic rehabilitation unit of a teaching hospital between July 2010 and March 2011. Outcome measures were BI changes (BI on discharge - BI on admission) during rehabilitation (primary outcome) and length of stay (secondary outcome).
Anticholinergic drugs were prescribed in 38 patients (32.5%). Median and interquartile range for tAD = 0 (0-1); for ARS = 0 (0-1). Poisson regression showed that higher tAD (incidence rate ratio [IRR] = 0.92; 95% CI, 0.88-0.97; P = 0.003) and ARS scores (IRR = 0.97; 95% CI, 0.95-0.99; P = 0.008) on admission independently predicted lower BI changes. Being a woman (IRR = 0.87; 95% CI, 0.78-0.97; P = 0.01), lower Abbreviated Mental Test scores (IRR = 0.94; 95% CI, 0.91-0.97; P < 0.001), and lower BI on admission (IRR = 0.98; 95% CI, 0.97-0.98; P < 0.001), but not tAD or ARS scores, independently predicted increasing length of stay.
Higher anticholinergic drug exposure on admission independently predicts reduced functional outcomes, but not length of stay, in older patients undergoing orthopaedic rehabilitation.
具有抗胆碱能(抗毒蕈碱)作用的药物会对社区老年患者的身体和认知功能产生负面影响。然而,抗胆碱能药物在接受康复治疗的老年患者中是否产生有害影响尚不清楚。
我们研究的目的是评估抗胆碱能药物暴露对接受康复治疗的老年患者功能结局的影响。我们推测,在该组患者中,更高的抗胆碱能药物暴露与功能结局降低有关。
收集了2010年7月至2011年3月期间连续入住一家教学医院骨科康复科的117例老年患者(年龄79[7]岁)入院和出院时的临床特征、完整用药情况、抗胆碱能药物暴露情况(抗胆碱能药物总数[tAD]和抗胆碱能风险量表[ARS]评分)以及Barthel指数(BI)评分。结局指标为康复期间的BI变化(出院时的BI-入院时的BI)(主要结局)和住院时间(次要结局)。
38例患者(32.5%)使用了抗胆碱能药物。tAD的中位数和四分位间距=0(0-1);ARS的中位数和四分位间距=0(0-1)。泊松回归显示,入院时较高的tAD(发病率比[IRR]=0.92;95%CI,0.88-0.97;P=0.003)和ARS评分(IRR=0.97;95%CI,0.95-0.99;P=0.008)独立预测较低的BI变化。女性(IRR=0.87;95%CI,0.78-0.97;P=0.01)、较低的简易精神状态检查评分(IRR=0.94;95%CI,0.91-0.97;P<0.001)以及入院时较低的BI(IRR=0.98;95%CI,0.97-0.98;P<0.001),而非tAD或ARS评分,独立预测住院时间延长。
入院时较高的抗胆碱能药物暴露独立预测接受骨科康复治疗的老年患者功能结局降低,但不能预测住院时间。